|
Wednesday, February 28, 2007
Trius Therapeutics Finds $20M
San Diego-based Trius Therapeutics, a company developing antibacterial drugs for the treatment of serious infections, has raised $20M in a Series A funding. The funding came from Sofinnova Ventures, which led the deal, and also included InterWest Partners, Prism VentureWorks, and Versant Ventures. Trius Therapeutics was formerly known as Rx3 Pharmaceuticals.
posted on Wednesday, February 28, 2007 (Link to more information)
|
 RSS
 Email
Twitter
Previous news:
Friday, November 21, 2008
Thursday, November 20, 2008
Wednesday, November 19, 2008
Tuesday, November 18, 2008
Monday, November 17, 2008
|
